CCN2 and prostate carcinoma: A previous study indicated that CTGF expression in high bone metastatic prostate cancer cells was 1.9 times higher than in low bone metastatic prostate cancer cells, and the increased CTGF expression did not affect tumor cell proliferation but significantly expanded the tumor area at the site of bone metastasis [53].